Inflammatory biomarkers, multi-morbidity, and biologic aging. Issue 7 (July 2022)

• Record Type: Journal Article
• Authors: St. Sauver, Jennifer; Rocca, Walter; LeBrasseur, Nathan; Chamberlain, Alanna; Olson, Janet; Jacobson, Debra; McGree, Michaela; Mielke, Michelle
• Is Part Of: Journal of international medical research. Volume 50:Issue 7(2022)
• Publication Date: 2022-07
• Subjects: Comorbidity -- multiple chronic conditions -- interleukin-6 -- tumor necrosis factor-α -- interleukin-10 -- clinical aging -- inflammatory marker; Medicine -- Periodicals; Pharmacology -- Periodicals; 610.5
• DOI: 10.1177/03000605221109393
• Languages: English
• ISSNs: 0300-0605

Abstract

Objectives: To study the association between multi-morbidity percentiles, which is a measure of clinical aging, and interleukin (IL)-6, IL-10, and tumor necrosis factor (TNF)-α. Methods: Participants 50 to 95 years of age from the Mayo Clinic Study of Aging were assigned age- and sex-specific multi-morbidity percentiles using look-up tables that were reported previously (n = 1646). Percentiles were divided into quintiles for analysis. Plasma IL-6, IL-10, and TNF-α levels were measured in 1595 participants. Median inflammatory marker levels were compared across multi-morbidity quintiles using nonparametric tests. Results: People with higher multi-morbidity percentiles had significantly higher IL-6 and TNF-α levels compared with those with lower multi-morbidity percentiles. Tests for trend across five multi-morbidity quintiles were significant among women for IL-6 and among participants 70 years of age or older for IL-6 and TNF-α. IL-10 was not associated with multi-morbidity percentiles. Conclusions: Multi-morbidity percentiles may be a useful clinical index of biological age for future studies, particularly in women and people 70 years of age and older.